Additionally, the genetic background also modulates metabolic responses, with mouse models with a B6 background exhibiting stronger microglial activation, while 129S1/SvImJ-based models like 3xTg-AD demonstrate more severe tau-related neurodegeneration under inflammatory conditions [44]. This evidence concerns the gene MAPT and Alzheimer disease.